Endpoints | Ranks | DC | MDC | MDCI |
---|---|---|---|---|
Overall survival (HR (95% CrI)) | Rank 1 | 0.07 | 0.20 | 0.73 |
Rank 2 | 0.21 | 0.67 | 0.13 | |
Rank 3 | 0.72 | 0.13 | 0.14 | |
Progression-free survival (HR (95% CrI)) | Rank 1 | 0.18 | 0.30 | 0.52 |
Rank 2 | 0.23 | 0.53 | 0.24 | |
Rank 3 | 0.59 | 0.17 | 0.24 | |
Total severe events (OR (95% CrI)) | Rank 1 | 0.75 | 0.11 | 0.14 |
Rank 2 | 0.20 | 0.68 | 0.12 | |
Rank 3 | 0.05 | 0.21 | 0.74 | |
Leukopenia (OR (95% CrI)) | Rank 1 | 0.69 | 0.12 | 0.18 |
Rank 2 | 0.21 | 0.69 | 0.10 | |
Rank 3 | 0.10 | 0.18 | 0.72 | |
Thrombocytopenia (OR (95% CrI)) | Rank 1 | 0.72 | 0.14 | 0.14 |
Rank 2 | 0.20 | 0.73 | 0.07 | |
Rank 3 | 0.07 | 0.13 | 0.79 | |
RBC transfusion (OR (95% CrI)) | Rank 1 | 0.55 | 0.31 | 0.14 |
Rank 2 | 0.30 | 0.43 | 0.27 | |
Rank 3 | 0.15 | 0.25 | 0.60 | |
PLT transfusion (OR (95% CrI)) | Rank 1 | 0.63 | 0.20 | 0.17 |
Rank 2 | 0.19 | 0.58 | 0.22 | |
Rank 3 | 0.19 | 0.21 | 0.59 | |
G-CSF (OR (95% CrI)) | Rank 1 | 0.71 | 0.12 | 0.17 |
Rank 2 | 0.22 | 0.67 | 0.11 | |
Rank 3 | 0.07 | 0.20 | 0.73 | |
Hospitalization (OR (95% CrI)) | Rank 1 | 0.74 | 0.10 | 0.16 |
Rank 2 | 0.21 | 0.69 | 0.10 | |
Rank 3 | 0.05 | 0.21 | 0.74 |